Floatz logo

Acetylsalicylic Acid

OligoProgressive Metastatic Disease

Shanghai Chest HospitalPhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the OligoProgressive Metastatic Disease cohort.

Asset / SponsorPhaseRating
Plavix
Shanghai Chest Hospital
Phase 2/3B
FUROSEMIDE
Shanghai Chest Hospital
Phase 2/3B
Spironolactone
Shanghai Chest Hospital
Phase 2/3B
Imsa101
University of Texas Southwestern Medical Center
Phase 2CCC

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →